European Trade Group Urges Transparency In China Compliance Probe
This article was originally published in PharmAsia News
European pharmaceutical firms are working to handle the fallout from the ongoing compliance probe into sales and marketing practices. And the European Chamber of Commerce in China said lessons learned may prove invaluable for companies as they assess China growth prospects and business opportunities.
You may also be interested in...
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
China insurance giant snatches up stakes in Japanese pharma and a traditional Chinese medicines maker with a $465m spending spree.
With vaccines perhaps the ultimate weapon to fight the coronavirus, a developer in China sees a big chunk of investment with potentially more companies to see funding coming.